Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$546.89 -11.07 (-1.98%)
As of: Sep 4, 2026 · 2:26 PM EDT

Vertex Pharmaceuticals (VRTX) Gross Margin (QoQ) (2009 - 2026)

Analysis

Vertex Pharmaceuticals (VRTX) Gross Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn
5 Revolution Medicines 44.07 Bn 44.07 Bn -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn
10 Incyte 25.64 Bn 21.11 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -152.00
Mar 31, 2026 146.00
Dec 31, 2025 -112.00
Sep 30, 2025 26.00
Jun 30, 2025 -64.00
Mar 31, 2025 144.00
Dec 31, 2024 -38.00
Sep 30, 2024 -11.00
Jun 30, 2024 -132.00
Mar 31, 2024 188.00
Dec 31, 2023 -178.00
Sep 30, 2023 -46.00
Jun 30, 2023 -114.00
Mar 31, 2023 106.00
Dec 31, 2022 9.00
Sep 30, 2022 -48.00
Jun 30, 2022 -20.00
Mar 31, 2022 22.00
Dec 31, 2021 -2.00
Sep 30, 2021 79.00